Company Profile
Updated: 17-SEP-09Merck Serono S.A.
International subsidiary
PO Box 54, Geneva, 1202, Switzerland
()22 7393000, 22 7312179 fax, http://www.serono.com
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Genetic engineering and other products, such as neurological, metabolic, and human growth disorders products, multiple sclerosis, growth hormone deficiency, and AIDS-related wasting.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Flamel Technologies Announces Third Quarter 2009 Results; Additional New Projects; Cash Increases from $45.1 to $48.8 million.(Financial report)
Business Wire; 11/16/2009; 1333 words; ...increase in the Company's cash and marketable securities...Stephen H. Willard, Flamel's chief executive officer...including those with GSK, Merck Serono, Pfizer, and Baxter. We...for investors in the U.S. and Canada) is 1-800...
Phase Forward CFO Chris Menard to Present at 2009 MIT Sloan CFO Summit.
Business Wire; 11/16/2009; 804 words; ...from MIT Sloan with today's corporate financial leaders...safety. Phase Forward's products and services have...Institute, Eli Lilly, the U.S. Food and Drug Administration...Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk...
Aegis Releases Discoverant 3.4 Enterprise Manufacturing Intelligence Software.
Business Wire; 11/16/2009; 1050 words; ...Discoverant is used by many of the world's life sciences manufacturers including...Myers Squibb, Eli Lilly, Genzyme, Merck Serono and others for better process understanding...analytics and reporting. The company's enterprise-class software platform...
www.Xtremepicks.Com: Xtremepicks Alerts November 16, 2009 : PFWD, TECD, SBLK and GABC.
M2 Presswire; 11/16/2009; 1744 words; ...safety. Phase Forward's products and services have...Institute, Eli Lilly, the U.S. Food and Drug Administration...Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk...Tech Builds upon Tech Data's Extensive Experience Supporting...
Columbia Laboratories Comments on Stock Activity.
Business Wire; 11/13/2009; 945 words; ...expectations regarding the Company's strategic direction, prospects...buccal system) in the U.S.; the successful marketing of CRINONE[R] 8% by Merck Serono; the timely and successful...the strength of the U.S. dollar relative to international...
Recent News Articles
- Merck Serono Growth Hormone Injection Device easypod[R] Approved in Japan.
Biotech Week - September 30, 2009 - Nearly Ninety Percent of Surveyed Neurologists Indicate They Will Prescribe Merck Serono/EMD Serono's Oral Cladribine for the Treatment of Multiple Sclerosis.
Biotech Week - September 23, 2009 - MERCK SERONO TO PRESENT NEW DATA AT ECCO/ESMO ONCOLOGY CONGRESS.
AsiaPulse News - September 11, 2009 - Nearly Ninety Percent of Surveyed Neurologists Indicate They Will Prescribe Merck Serono/EMD Serono's Oral Cladribine for the Treatment of Multiple Sclerosis.
PR Newswire - September 09, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning